The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Pediatric Pulmonology
Volume 13 - 2025 |
doi: 10.3389/fped.2025.1558256
Characteristics of children with severe preschool asthma prior to starting the TIPP Study
Provisionally accepted- 1 Institute for respiratory research, Medaimun GmbH, Frankfurt am Main, Germany
- 2 Department of pediatrics, Goethe-University, Frankfurt, Germany
- 3 Interdisciplinary Center for Clinical Studies, University Medical Centre, Johannes Gutenberg University Mainz, Mainz, Rhineland-Palatinate, Germany
- 4 Children's Hospital, Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany
- 5 Pediatric Allergology, Department of Pediatrics, Dr. von Hauner Children's University Hospital, LMU Munich-Member of the German Center for Lung Research-DZL-LMU Munich, Munic, Germany
- 6 University of Leipzig, Medical Center, Department of Pediatrics,, Leipzig, Germany
- 7 Klinik für Kinder- und Jugendmedizin, Universität Jena,, Jena, Germany
- 8 Department for Pediatric Cardiology, Intensive Care and Neonatology, University Medicine, Göttingen, Germany
- 9 Kinderlungen-Facharzt, Gemeinschaftspraxis in Mannheim, Mannheim, Germany
- 10 Department of Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany
- 11 Department of Pediatrics, Children's Center Bethel, University Medicine, Bielefeld, Germany
- 12 Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum Carl Gustav Carus an der Technischen Universität, Dresden, Germany
- 13 Kinderklinik, Universitätsklinikum Augsburg, Augsburg, Germany
- 14 Clinic for Pediatric Pneumology, Allergology and Neonatology, Center for Pediatrics and Adolescent Medicine, Hannover Medical School, Hannover, Lower Saxony, Germany
Objective: Children with preschool asthma suffer disproportionally more often from severe asthma exacerbations with emergency visits and hospital admissions than school children. However, there are only a few reports on characteristics, hospitalization, phenotypes and symptoms in this age cohort.Patients and Methods: This analysis of an ongoing prospective trial of Tiotropium bromide in preventing severe asthma exacerbations (the TIPP study) assessed baseline characteristics, hospitalizations and symptoms in 100 children with severe preschool asthma. Children aged 1-5 years were analyzed at study enrollment and daily symptoms were recorded by an electronic diary (Pediatric Asthma Caregiver Diary [PACD]) for the following four weeks until randomization.Results: At enrollment, the total number of severe asthma exacerbations, defined as three days systemic steroid use or hospitalization in the last 24 months, was mean (± SD) 5.8 ± 5.7 and the test for respiratory and asthma control in kids (TRACK) was mean 46.9 ± 19.0. Daily recording of symptoms by the PACD revealed that only 7 patients were controlled at randomization, whereas 35 were partially and 58 were uncontrolled according to GINA.Despite protective therapy with inhaled corticosteroids (ICS), most children of this severe asthma cohort were only partially or uncontrolled according to GINA guidelines.
Keywords: preschool asthma, Uncontrolled asthma, PACD, Hospitalization, Asthma phenotypes, tiotropium bromide
Received: 09 Jan 2025; Accepted: 06 Feb 2025.
Copyright: © 2025 Zielen, Wosniok, Wollscheid, Nickolay, Grimmel, Scheele, Sattler, Prenzel, Lorenz, Prof. Dr. Schaub, Lex, Dahlheim, Trischler, Donath, Lau, Hamelmann, Vogelberg, Gerstlauer, Wetzke, Schubert, Schollenberger and Gappa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Stefan Zielen, Institute for respiratory research, Medaimun GmbH, Frankfurt am Main, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.